السفري 150مجم 20 كبسول

ما هو دواء السفري 150مجم 20 كبسول

جرعة دواءالسفري 150مجم 20 كبسول

يستعمل دواء السفري 150مجم 20 كبسولulcfree 150mg 20 caps. peptic ulcer.anti-histamine.h2 antagonist peptic ulcer.anti-histamine.h2 antagonist

indication -for the treatment of acid-reflux disorders (gerd) peptic ulcer disease active benign gastric ulcer and active duodenal ulcer. -pharmacodynamics -nizatidine is a competitive reversible inhibitor of histamine at the histamine h2-receptors particularly those in the gastric parietal cells. by inhibiting the action of histamine on stomach cells nizatidine reduces stomach acid production. nizatidine had no demonstrable antiandrogenic action. full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. it has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers. - -mechanism of action -nizatidine competes with histamine for binding at the h2-receptors on the gastric basolateral membrane of parietal cells. competitive inhibition results in reduction of basal and nocturnal gastric acid secretions.

تركيبة دواءالسفري 150مجم 20 كبسولulcfree 150mg 20 caps.

يتركب هذا الدواء من :nizatidine